Comparison

Vemurafenib European Partner

Item no. TMO-T2382-1000mg
Manufacturer TargetMol
CASRN 918504-65-1
Amount 1000 mg
Quantity options 1000 mg 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 200 mg 25 mg 500 mg 50 mg
Category
Type Molecules
Specific against other
Citations 1. Bollag G, et al. Nature, 2010, 467(7315), 596-599.
Smiles C(=O)(C=1C=2C(NC1)=NC=C(C2)C3=CC=C(Cl)C=C3)C4=C(F)C(NS(CCC)(=O)=O)=CC=C4F
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias RO5185426,RG7204,PLX4032
Shipping Condition Cool pack
Available
Manufacturer - Targets
Src|||Raf|||MAPK|||Autophagy|||ACK1
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
489.92
Description
Vemurafenib (RG7204) is a B-RAF inhibitor that inhibits RAFV600E and c-RAF-1 (IC50=31/48 nM) selectively and potently. Vemurafenib exhibits antitumor activity and is used for the treatment of BRAF V600E mutation-positive melanoma.
Pathways
MAPK|||Autophagy|||Tyrosine Kinase/Adaptors|||Angiogenesis
Bioactivity
Vemurafenib (PLX4032, RG7204) is a novel and potent inhibitor of B-RafV600E with IC50 of 31 nM in cell-free assay
Receptor
ACK1; BLK; BRK; MAP4K5 (KHS1); NEK11; MNK2; B-Raf; B-Raf (V600E); C-Raf; SRMS; Lyn B; FGR; Lck; Src; Yes1; CSK; FRK (PTK5); WNK3

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1000 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close